Some Boston firms are set to profit from the major merger between Pfizer and Irish drug maker Allergan.
The deal was announced just before Thanksgiving.
Wellington Management is set to make nearly $1 billion.
Wellington is the fourth largest shareholder of Allergan.
Two other Boston-based firms are also expected to profit off the deal.
The total value of the deal was $160 billion when it was announced last week.